Prognostic value of CD4<sup>+</sup> in patients with Т1-2N0M0 breast cancer
Aim. To evaluate the prognostic value of CD4+ in patients with T1-2N0M0 breast cancer.Materials and methods. We performed a quantitative assessment of CD4+ T-lymphocytes in tumor stromal cells and determined the prognostic parameter using the method developed by us (patent No. RU2697709C1 dated 19.0...
Saved in:
Main Authors: | R. M. Paltuev (Author), A. G. Kudaybergenova (Author), V. F. Semiglazov (Author), A. V. Komyakhov (Author), A. I. Tseluyko (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic value of FOXA1 in patients with Т1-2N0M0 breast cancer
by: R. M. Paltuev, et al.
Published: (2023) -
Prognostic and predictive value of a novel 100-point scale in patients with T1-2N0M0 breast cancer
by: R. M. Paltuev, et al.
Published: (2023) -
Prognostic factors in T3-Т4N0M0 breast cancer
by: I. V. Vysotskaya, et al.
Published: (2014) -
General recommendations for the management of breast cancer (St. Gallen Expert Consensus developed at the 16<sup>th </sup>th International Breast Cancer Conference)
by: V. F. Semiglazov, et al.
Published: (2020) -
Differential expression of HIF-1α in CD44<sup>+</sup>CD24<sup>-/low </sup>breast ductal carcinomas
by: Soares Fernando A, et al.
Published: (2011)